Portal de Periódicos da CAPES

Determination of cardiac involvement in sarcoidosis by magnetic resonance imaging and Doppler echocardiography

2002; Wiley; Volume: 252; Issue: 5 Linguagem: Inglês

10.1046/j.1365-2796.2002.01058.x

1365-2796

C. Magnus Sköld, Flemming Larsen, E. Rasmussen, S. KENNETH PEHRSSON, Anders Eklúnd,

Cardiac Imaging and Diagnostics

Abstract. Sköld CM, Larsen FF, Rasmussen E, Pehrsson SK, Eklund AG (Karolinska Hospital and Institutet, Stockholm, Sweden). Determination of cardiac involvement in sarcoidosis by magnetic resonance imaging and Doppler echocardiography. J Intern Med 2002; 252: 465–471. Objectives. To elucidate whether cardiac magnetic resonance imaging (MRI) could be useful in disclosing structural changes in the myocardium in sarcoidosis patients and to relate echo‐Doppler derived indices of left ventricular function to electrocardiogram (ECG) findings. Design. The MRI was performed in 18 consecutive patients with sarcoidosis. Left ventricular ejection fraction (LVEF), i.e. systolic function, was estimated echocardiographically by Simpson's two‐dimensional method ( n = 16). Diastolic function was estimated by age‐corrected Doppler‐derived indices: isovolumetric relaxation time (IVRT), deceleration time (DT) and early filling/atrial contraction ratio (E/A ratio). Results. Eleven patients had conduction defects or dysrhythmias (ECG+) whilst seven patients had a normal ECG (ECG–). In two patients, high signalling, contrast‐enhanced, isolated regions, suggestive of deposits, were seen in the left ventricular myocardium on MRI. Both these patients had abnormal ECGs and signs of systolic and/or diastolic dysfunction on echocardiography. LVEF was subnormal in seven of 10 of the ECG+ patients and in two of six of the ECG–. Signs of diastolic dysfunction were found in 59% and 56% of the measurements in the ECG+ and ECG– patients, respectively. Conclusion. We conclude (i) that myocardial deposits on MRI in sarcoidosis patients have a high specificity for cardiac involvement but a rather low sensitivity; (ii) that a substantial proportion of sarcoidosis patients with abnormal ECGs have echocardiographic signs of systolic and/or diastolic dysfunction.